表紙:外傷固定用デバイス - 医療機器のパイプライン評価
市場調査レポート
商品コード
915752

外傷固定用デバイス - 医療機器のパイプライン評価

Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 271 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.49円
外傷固定用デバイス - 医療機器のパイプライン評価
出版日: 2020年12月01日
発行: GlobalData
ページ情報: 英文 271 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、現在パイプライン段階にある外傷固定用デバイスについて調査分析し、開発段階別の比較分析に焦点を当てて、主要企業、進行中の治験情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 外傷固定用デバイスの概要

第3章 開発中の製品

  • 外傷固定用デバイス - パイプライン製品:開発段階別
  • 外傷固定用デバイス - パイプライン製品:セグメント別
  • 外傷固定用デバイス - パイプライン製品:地域別
  • 外傷固定用デバイス - パイプライン製品:規制経路別
  • 外傷固定用デバイス - パイプライン製品:承認時期別 (予定)
  • 外傷固定用デバイス - 進行中の治験

第4章 外傷固定用デバイス:開発中のパイプライン製品 (企業別)

  • 外傷固定用デバイス企業 - パイプライン製品:開発段階別
  • 外傷固定用デバイス - パイプライン製品:開発段階別

第5章 外傷固定用デバイス企業と製品の概要

  • 206 Ortho, Inc.
  • 4WEB Medical Inc
  • aap Implantate AG
  • Advanced BioMedical Technologies, Inc.
  • AMB Surgical II LLC
  • Apex Biomedical LLC
  • Appiades Meditech ltd.
  • Argomedical AG
  • Ascendx Spine, Inc. (休止中)
  • B1 Medical Ltd (休止中)
  • Bactiguard Holding AB
  • BioMagnesium Systems Ltd. (休止中)
  • Bioretec Ltd
  • Body Organ Biomedical Corp
  • CAMBfix Ltd (休止中)
  • Cardinal Health Inc
  • Clemson University
  • Columbia University
  • Conventus Orthopaedics
  • Curtin University
  • Dallen Medical
  • DePuy Synthes Inc
  • Drexel University
  • DSM Biomedical BV
  • Dynamic Memory Medical Technologies Ltd.
  • Endoorthopaedics, Inc.
  • Evonik Corp
  • Expanding Orthopedics Inc
  • Hannover Medical School
  • Hospital for Special Surgery
  • Implants International Ltd
  • Innovia LLC
  • Interface Biologics Inc
  • Intrafuse LLC
  • Intramed Systems Ltd
  • Johns Hopkins University
  • Koc Universitesi
  • McGill University
  • Medartis AG
  • Medtronic plc
  • Meta Biomed Co Ltd
  • MicroPort Scientific Corp
  • 名古屋大学
  • Nanova, Inc
  • Nasseo, Inc.
  • Nextremity Solutions, LLC.
  • Nuortho Surgical Inc
  • Nutek Orthopaedics Inc
  • OrthoMend Research Inc
  • OrthoPediatrics Corp
  • OrthoSensor Inc
  • Orthospin Ltd
  • OrthoXel DAC
  • Ossio Ltd
  • Osteo Pharma BV
  • Ostiio
  • Resoimplant GmbH (休止中)
  • Resorbium Ltd
  • Response Ortho
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Saint Louis University
  • Sayan Orthopaedics Ltd
  • SeaSpine, Inc.
  • SINTX Technologies Inc
  • Small Bone Innovations Inc
  • Smith & Nephew Plc
  • SpineSmith Holdings LLC
  • SUNY Upstate Medical University
  • Synoste Oy
  • Teleflex Inc
  • Tepha Inc
  • Tesa Medical, Inc.
  • The Feinstein Institute for Medical Research
  • Tornier Inc
  • Treace Medical Concepts, Inc.
  • Tyber Medical LLC
  • University of Alabama
  • University of Alabama at Birmingham
  • University of Colorado
  • University of Kansas
  • University of Massachusetts Worcester Campus
  • University of Michigan Pediatric Device Consortium
  • University of Nevada Reno
  • University of North Carolina at Chapel Hill
  • University of Nottingham
  • University of Oxford
  • University of South Florida
  • University of Texas Health Science Center at San Antonio
  • University of Texas Medical Branch at Galveston
  • University of Texas Southwestern Medical Center
  • University of Toledo
  • University of Utah
  • University of Washington
  • Vertech Inc
  • Wright Medical Group NV
  • Yale University

第6章 外傷固定用デバイス - 最近の動向

第7章 付録

図表

List of Tables

List of Tables

  • Table 1: Trauma Fixation - Pipeline Products by Stage of Development
  • Table 2: Trauma Fixation - Pipeline Products by Segment
  • Table 3: Trauma Fixation - Pipeline Products by Territory
  • Table 4: Trauma Fixation - Pipeline Products by Regulatory Path
  • Table 5: Trauma Fixation - Pipeline Products by Estimated Approval Date
  • Table 6: Trauma Fixation - Ongoing Clinical Trials
  • Table 7: Trauma Fixation Companies - Pipeline Products by Stage of Development
  • Table 8: Trauma Fixation - Pipeline Products by Stage of Development
  • Table 9: 206 Ortho, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Ortho Implant - Product Status
  • Table 11: Ortho Implant - Product Description
  • Table 12: 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Truss Implant - Trauma Procedures - Product Status
  • Table 14: Truss Implant - Trauma Procedures - Product Description
  • Table 15: aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Loqteq Antibacterial Plate - Product Status
  • Table 17: Loqteq Antibacterial Plate - Product Description
  • Table 18: LOQTEQ VA Hook Plate 2.5 - Product Status
  • Table 19: LOQTEQ VA Hook Plate 2.5 - Product Description
  • Table 20: LOQTEQ VA L-Fusion Plate 2.5 - Product Status
  • Table 21: LOQTEQ VA L-Fusion Plate 2.5 - Product Description
  • Table 22: LOQTEQ VA Metatarsal L-Plate 2.5 - Product Status
  • Table 23: LOQTEQ VA Metatarsal L-Plate 2.5 - Product Description
  • Table 24: LOQTEQ VA Metatarsal Straight Plate 2.5 - Product Status
  • Table 25: LOQTEQ VA Metatarsal Straight Plate 2.5 - Product Description
  • Table 26: LOQTEQ VA Metatarsal T-Plate 2.5 - Product Status
  • Table 27: LOQTEQ VA Metatarsal T-Plate 2.5 - Product Description
  • Table 28: LOQTEQ VA MTP Fusion Plate 2.5 - Product Status
  • Table 29: LOQTEQ VA MTP Fusion Plate 2.5 - Product Description
  • Table 30: LOQTEQ VA MTP Revision Plate 2.5 - Product Status
  • Table 31: LOQTEQ VA MTP Revision Plate 2.5 - Product Description
  • Table 32: LOQTEQ VA Osteotomy Plate 2.5 - Product Status
  • Table 33: LOQTEQ VA Osteotomy Plate 2.5 - Product Description
  • Table 34: LOQTEQ VA Plantar Fusion Plate 2.5 - Product Status
  • Table 35: LOQTEQ VA Plantar Fusion Plate 2.5 - Product Description
  • Table 36: LOQTEQ VA Resorbable - Pin - Product Status
  • Table 37: LOQTEQ VA Resorbable - Pin - Product Description
  • Table 38: LOQTEQ VA Resorbable - Plate - Product Status
  • Table 39: LOQTEQ VA Resorbable - Plate - Product Description
  • Table 40: LOQTEQ VA Resorbable - Screw - Product Status
  • Table 41: LOQTEQ VA Resorbable - Screw - Product Description
  • Table 42: LOQTEQ VA Straight Fusion Plate 2.5 - Product Status
  • Table 43: LOQTEQ VA Straight Fusion Plate 2.5 - Product Description
  • Table 44: LOQTEQ VA Tibia Plates - Product Status
  • Table 45: LOQTEQ VA Tibia Plates - Product Description
  • Table 46: LOQTEQ VA X-Plate 2.5 - Product Status
  • Table 47: LOQTEQ VA X-Plate 2.5 - Product Description
  • Table 48: PMMA Augmented LOQTEQ Implant - Product Status
  • Table 49: PMMA Augmented LOQTEQ Implant - Product Description
  • Table 50: aap Implantate AG - Ongoing Clinical Trials Overview

List of Figures

List of Figures

  • Figure 1: Trauma Fixation - Pipeline Products by Stage of Development
  • Figure 2: Trauma Fixation - Pipeline Products by Segment
  • Figure 3: Trauma Fixation - Pipeline Products by Territory
  • Figure 4: Trauma Fixation - Pipeline Products by Regulatory Path
  • Figure 5: Trauma Fixation - Pipeline Products by Estimated Approval Date
  • Figure 6: Trauma Fixation - Ongoing Clinical Trials
目次
Product Code: GDME1084EPD

GlobalData's Medical Devices sector report, "Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Trauma Fixation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Trauma Fixation devices are used for the treatment of fractures. These devices provide support for aligning, stabilizing and immobilization of fractured bones. Trauma fixation devices are broadly classified into two types - Internal Fixators and External Fixators.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Trauma Fixation Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Trauma Fixation Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Trauma Fixation Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Trauma Fixation Overview

3 Products under Development

  • 3.1 Trauma Fixation - Pipeline Products by Stage of Development
  • 3.2 Trauma Fixation - Pipeline Products by Segment
  • 3.3 Trauma Fixation - Pipeline Products by Territory
  • 3.4 Trauma Fixation - Pipeline Products by Regulatory Path
  • 3.5 Trauma Fixation - Pipeline Products by Estimated Approval Date
  • 3.6 Trauma Fixation - Ongoing Clinical Trials

4 Trauma Fixation - Pipeline Products under Development by Companies

  • 4.1 Trauma Fixation Companies - Pipeline Products by Stage of Development
  • 4.2 Trauma Fixation - Pipeline Products by Stage of Development

5 Trauma Fixation Companies and Product Overview

  • 5.1 206 Ortho, Inc. Company Overview
    • 5.1.1 206 Ortho, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 4WEB Medical Inc Company Overview
    • 5.2.1 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 aap Implantate AG Company Overview
    • 5.3.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Acuitive Technologies Inc Company Overview
    • 5.4.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Advanced BioMedical Technologies, Inc. Company Overview
    • 5.5.1 Advanced BioMedical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 AMB Surgical II LLC Company Overview
    • 5.6.1 AMB Surgical II LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Apex Biomedical LLC Company Overview
    • 5.7.1 Apex Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Appiades Meditech ltd. Company Overview
    • 5.8.1 Appiades Meditech ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Argomedical AG Company Overview
    • 5.9.1 Argomedical AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Ascendx Spine, Inc. (Inactive) Company Overview
    • 5.10.1 Ascendx Spine, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 B1 Medical Ltd (Inactive) Company Overview
    • 5.11.1 B1 Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Bactiguard Holding AB Company Overview
    • 5.12.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 BioMagnesium Systems Ltd. (Inactive) Company Overview
    • 5.13.1 BioMagnesium Systems Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Bioretec Ltd Company Overview
    • 5.14.1 Bioretec Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Body Organ Biomedical Corp Company Overview
    • 5.15.1 Body Organ Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Camber Spine Technologies LLC Company Overview
    • 5.16.1 Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 CAMBfix Ltd (Inactive) Company Overview
    • 5.17.1 CAMBfix Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Cardinal Health Inc Company Overview
    • 5.18.1 Cardinal Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Clear Surgical Ltd Company Overview
    • 5.19.1 Clear Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Clemson University Company Overview
    • 5.20.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Columbia University Company Overview
    • 5.21.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Conventus Orthopaedics Company Overview
    • 5.22.1 Conventus Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Coracoid Solutions LLC Company Overview
    • 5.23.1 Coracoid Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Curtin University Company Overview
    • 5.24.1 Curtin University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Dallen Medical Company Overview
    • 5.25.1 Dallen Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 DePuy Synthes Inc Company Overview
    • 5.26.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Drexel University Company Overview
    • 5.27.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 DSM Biomedical BV Company Overview
    • 5.28.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Dynamic Memory Medical Technologies Ltd. Company Overview
    • 5.29.1 Dynamic Memory Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Endoorthopaedics, Inc. Company Overview
    • 5.30.1 Endoorthopaedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 Evonik Corp Company Overview
    • 5.31.1 Evonik Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Expanding Orthopedics Inc Company Overview
    • 5.32.1 Expanding Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 ExsoMed Corp Company Overview
    • 5.33.1 ExsoMed Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 FH Industrie Company Overview
    • 5.34.1 FH Industrie Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 Gramercy Extremity Orthopedics LLC Company Overview
    • 5.35.1 Gramercy Extremity Orthopedics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 Hannover Medical School Company Overview
    • 5.36.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 Hospital for Special Surgery Company Overview
    • 5.37.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 Implants International Ltd Company Overview
    • 5.38.1 Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 Innovia LLC Company Overview
    • 5.39.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 Interface Biologics Inc Company Overview
    • 5.40.1 Interface Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 Intramed Systems Ltd Company Overview
    • 5.41.1 Intramed Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42 Johns Hopkins University Company Overview
    • 5.42.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43 Koc Universitesi Company Overview
    • 5.43.1 Koc Universitesi Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44 McGill University Company Overview
    • 5.44.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45 Medshape Inc Company Overview
    • 5.45.1 Medshape Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46 Medtronic Plc Company Overview
    • 5.46.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47 Mel Frontier Co Ltd Company Overview
    • 5.47.1 Mel Frontier Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48 Meta Biomed Co Ltd Company Overview
    • 5.48.1 Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49 MicroPort Scientific Corp Company Overview
    • 5.49.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50 Nagoya University Company Overview
    • 5.50.1 Nagoya University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51 Nanova, Inc Company Overview
    • 5.51.1 Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52 Nasseo, Inc. Company Overview
    • 5.52.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53 NEOS Surgery SL Company Overview
    • 5.53.1 NEOS Surgery SL Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54 Nextremity Solutions, LLC. Company Overview
    • 5.54.1 Nextremity Solutions, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55 Nuortho Surgical Inc Company Overview
    • 5.55.1 Nuortho Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56 Nutek Orthopaedics Inc Company Overview
    • 5.56.1 Nutek Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57 OrthoMend Research Inc Company Overview
    • 5.57.1 OrthoMend Research Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58 OrthoPediatrics Corp Company Overview
    • 5.58.1 OrthoPediatrics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59 OrthoSensor Inc Company Overview
    • 5.59.1 OrthoSensor Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60 Orthospin Ltd Company Overview
    • 5.60.1 Orthospin Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61 Ossio Ltd Company Overview
    • 5.61.1 Ossio Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62 Osteo Pharma BV Company Overview
    • 5.62.1 Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.63 Ostiio Company Overview
    • 5.63.1 Ostiio Pipeline Products & Ongoing Clinical Trials Overview
  • 5.64 PainTEQ Company Overview
    • 5.64.1 PainTEQ Pipeline Products & Ongoing Clinical Trials Overview
  • 5.65 Paragon 28 Inc Company Overview
    • 5.65.1 Paragon 28 Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.66 Resoimplant GmbH (Inactive) Company Overview
    • 5.66.1 Resoimplant GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.67 Resorbium Ltd Company Overview
    • 5.67.1 Resorbium Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.68 Response Ortho Company Overview
    • 5.68.1 Response Ortho Pipeline Products & Ongoing Clinical Trials Overview
  • 5.69 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
    • 5.69.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.70 Saint Louis University Company Overview
    • 5.70.1 Saint Louis University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.71 Sayan Orthopaedics Ltd Company Overview
    • 5.71.1 Sayan Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.72 SeaSpine, Inc. Company Overview
    • 5.72.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.73 SINTX Technologies Inc Company Overview
    • 5.73.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.74 Smith & Nephew Plc Company Overview
    • 5.74.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.75 SpineSmith Holdings LLC Company Overview
    • 5.75.1 SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.76 Stryker Corp Company Overview
    • 5.76.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.77 SUNY Upstate Medical University Company Overview
    • 5.77.1 SUNY Upstate Medical University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.78 Synoste Oy Company Overview
    • 5.78.1 Synoste Oy Pipeline Products & Ongoing Clinical Trials Overview
  • 5.79 Syntellix AG Company Overview
    • 5.79.1 Syntellix AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.80 Teleflex Inc Company Overview
    • 5.80.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.81 Tepha Inc Company Overview
    • 5.81.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.82 Tesa Medical, Inc. Company Overview
    • 5.82.1 Tesa Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.83 The Feinstein Institute for Medical Research Company Overview
    • 5.83.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.84 The University of Nottingham Company Overview
    • 5.84.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
  • 5.85 Tornier Inc Company Overview
    • 5.85.1 Tornier Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.86 Tyber Medical LLC Company Overview
    • 5.86.1 Tyber Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.87 University of Alabama Company Overview
    • 5.87.1 University of Alabama Pipeline Products & Ongoing Clinical Trials Overview
  • 5.88 University of Alabama at Birmingham Company Overview
    • 5.88.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview
  • 5.89 University of Colorado Company Overview
    • 5.89.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • 5.90 University of Kansas Company Overview
    • 5.90.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.91 University of Massachusetts Worcester Campus Company Overview
    • 5.91.1 University of Massachusetts Worcester Campus Pipeline Products & Ongoing Clinical Trials Overview
  • 5.92 University of Michigan Pediatric Device Consortium Company Overview
    • 5.92.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
  • 5.93 University of Nebraska Company Overview
    • 5.93.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview
  • 5.94 University of Nevada Reno Company Overview
    • 5.94.1 University of Nevada Reno Pipeline Products & Ongoing Clinical Trials Overview
  • 5.95 University of North Carolina at Chapel Hill Company Overview
    • 5.95.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
  • 5.96 University of Oxford Company Overview
    • 5.96.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.97 University of South Florida Company Overview
    • 5.97.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.98 University of Texas Health Science Center at San Antonio Company Overview
    • 5.98.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview
  • 5.99 University of Texas Medical Branch at Galveston Company Overview
    • 5.99.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.100 University of Texas Southwestern Medical Center Company Overview
    • 5.100.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.101 University of Toledo Company Overview
    • 5.101.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
  • 5.102 University of Utah Company Overview
    • 5.102.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • 5.103 University of Washington Company Overview
    • 5.103.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
  • 5.104 Vertech Inc Company Overview
    • 5.104.1 Vertech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.105 Wright Medical Group NV Company Overview
    • 5.105.1 Wright Medical Group NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.106 Yale University Company Overview
    • 5.106.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview

6 Trauma Fixation- Recent Developments

  • 6.1 Oct 06, 2020: Tyber Medical launches clinical study for titanium integrated interbody devices
  • 6.2 Aug 13, 2020: Medline joins NPPGov as an approved vendor offering top-notch medical supplies
  • 6.3 Jul 28, 2020: Impressio and MedShape awarded competitive grant from the National Science Foundation to develop joint replacement device
  • 6.4 Jul 13, 2020: DSM appoints Cristina Monteiro new EVP People & Organization and member of the Executive Committee
  • 6.5 Jul 02, 2020: Osteopore signs initial U.S. distribution agreement
  • 6.6 Jul 01, 2020: DSM appoints Zhou Tao (Joe) as President DSM China
  • 6.7 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
  • 6.8 Jun 02, 2020: Evonik names new North America region chief
  • 6.9 May 28, 2020: Conformis announces settlement of patent dispute
  • 6.10 May 07, 2020: DSM to help accelerate Dutch Covid-19 testing by making 2.8 million nose swabs
  • 6.11 Apr 27, 2020: SpineGuard strengthens its IP with the grant of three new patents
  • 6.12 Apr 08, 2020: Wright Medical Group announces virtual meeting alternative to physical attendance at Extraordinary General Meeting of Shareholders and change of time and location of meeting
  • 6.13 Mar 13, 2020: Ossio gets FDA clearance for OSSIOfiber Hammertoe Fixation System
  • 6.14 Mar 04, 2020: TriMed, announces release of the ASET Foot Plating Systems
  • 6.15 Mar 03, 2020: Treace Medical announces publication of clinical data supporting Lapiplasty 3D bunion correction
  • 6.16 Mar 02, 2020: Stryker announces new Investor Relations leader
  • 6.17 Feb 25, 2020: New study gets to the root of fixing pediatric flatfeet
  • 6.18 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum
  • 6.19 Feb 25, 2020: DSM appoints new EVP Materials and member of the Executive Committee
  • 6.20 Feb 24, 2020: Positive signs for further growth in Asia: Syntellix receives product approvals in Malaysia and Myanmar earlier than planned
  • 6.21 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
  • 6.22 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
  • 6.23 Feb 20, 2020: Paragon 28 adds larger implant option to help address Hallux Malleus in their First-of-its-kind Hammertoe and Plantar Plate Repair Solution - TenoTac Soft Tissue Fixation System
  • 6.24 Feb 20, 2020: Teleflex reports fourth quarter and full year 2019 results; provides 2020 guidance
  • 6.25 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance
  • 6.26 Feb 18, 2020: Medtronic reports third quarter financial results 2020
  • 6.27 Feb 14, 2020: SpineGuard initiates safeguard proceedings while adapting its governance to strengthen the development of innovation
  • 6.28 Feb 13, 2020: Breakthrough study published measuring the effect of EOTTS to reduce Medial knee compartment forces
  • 6.29 Feb 13, 2020: DSM reports 2019 results
  • 6.30 Feb 12, 2020: 4WEB Medical Achieves Record Revenue in 2019
  • 6.31 Feb 10, 2020: MedShape announces positive early results with the DynaNail Mini
  • 6.32 Feb 07, 2020: Paratrooper Plantar Plate System receives 510(k) clearance - 1st dedicated system allowing surgeons to repair the plantar plate through either a dorsal or plantar approach
  • 6.33 Feb 07, 2020: Paragon 28 Phantom ActivCore Nail System Receives 510(k) Clearance - Continuous Compression Hindfoot Nail System
  • 6.34 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020
  • 6.35 Feb 05, 2020: Stryker expands Flower Mound regional headquarters
  • 6.36 Feb 04, 2020: AMDT Holdings initiates the launch of the SixFix Circular Fixation System
  • 6.37 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
  • 6.38 Jan 31, 2020: McGinley Orthopedics launches new plate for distal radius fractures: Lever Action Plate System
  • 6.39 Jan 28, 2020: aap Implantate AG: FY/19: Good fourth quarter with EUR 3.1 million revenue (+17%) results in 9% revenue growth in fiscal year 2019 - Milestones in key technologies silver coating and magnesium-based implants
  • 6.40 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook
  • 6.41 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
  • 6.42 Jan 23, 2020: Centinel Spine announces continued partnership with Performance Tech Motorsports
  • 6.43 Jan 20, 2020: DSM names Feike Sijbesma Honorary Chairman
  • 6.44 Jan 16, 2020: LimaCorporate inaugurates the new Research & Innovation Center for 3D printing and the Advanced Laboratory for Testing and Analysis (ATLAs)
  • 6.45 Jan 15, 2020: MEDICREA reports 2019 annual sales
  • 6.46 Jan 13, 2020: OrthoPediatrics reports preliminary unaudited revenue for fourth quarter and record setting full year 2019
  • 6.47 Jan 13, 2020: NuVasive announces preliminary unaudited fourth quarter and full year 2019 revenue results
  • 6.48 Jan 13, 2020: ATEC announces preliminary 2019 revenue results and 2020 revenue outlook
  • 6.49 Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer
  • 6.50 Jan 08, 2020: Globus Medical reports preliminary record fourth quarter and full year sales results
  • 6.51 Jan 06, 2020: Nextremity Solutions receives FDA 510(k) clearance for Lesser Tarsometatarsal (TMT) Joint Arthrodesis System
  • 6.52 Jan 06, 2020: Exactech announces leadership transition
  • 6.53 Jan 02, 2020: NuVasive appoints Matthew K. Harbaugh as chief financial officer
  • 6.54 Dec 23, 2019: Allegra receives funding through University of Sydney NHMRC grant
  • 6.55 Dec 13, 2019: SI-BONE announces CIGNA establishes positive coverage for MIS SI joint fusion using the iFuse Implant System
  • 6.56 Dec 13, 2019: Globus Medical announces Board of Director addition and departure
  • 6.57 Dec 10, 2019: TriMed announces receipt of 483 closeout letter from FDA
  • 6.58 Dec 09, 2019: Tyber Medical cuts ribbon on new $8 million office and manufacturing facility
  • 6.59 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business
  • 6.60 Dec 05, 2019: Ted Bird and David Gill join Bio2 Technologies Board of Directors
  • 6.61 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
  • 6.62 Dec 03, 2019: RTI Surgical accelerates business transformation with senior leadership appointments
  • 6.63 Dec 03, 2019: Kuros announces final result of Capital Increase - total gross proceeds of CHF 12.5 million raised

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer